beta

CORV

Correvio Pharma Corp.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients and healthcare systems. The company was founded in 1986 and is headquartered in Vancouver, Canada.

Market Cap: 27.8 Million

Primary Exchange: NASDAQ

Website: http://www.correvio.com

Shares Outstanding: 66.2 Million

Float: 61.3 Million

Dividend: (%)

Beta: -0.03597582832224281

Sector: Health Technology

Industry: Biotechnology

Ethical Flags

Longest drawdown: 1387 trading days

From: 2018-08-17 To: 2020-05-27

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud